Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: Aberrations of 17p mapped to, 17p13.2 by fluorescence in situ hybridization

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 518-525

  Althof, Pamela A ^a   Ohmori, Kazuo ^a   Zhou, Ming ^a   Bailey, Jacqueline M ^a   Bridge, R Stuart ^a   Nelson, Marilu ^a   Neff, James R ^a   Bridge, Julia A ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aneurysmal bone cyst; Cytogenetics; Fluorescence in situ hybridization

Indexed keywords

ADOLESCENT; ADULT; ANEURYSMAL BONE CYST; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHILD; CHROMOSOMAL LOCALIZATION; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CYTOGENETICS; DIAGNOSTIC VALUE; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; HUMAN; INTERPHASE; KARYOTYPE; MALE; METAPHASE; MILLER DIEKER SYNDROME; MOLECULAR GENETICS; PRIORITY JOURNAL; TP53 GENE;

ADULT; BONE CYSTS, ANEURYSMAL; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 6; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INVERSION, CHROMOSOME; KARYOTYPING; MALE; TRANSLOCATION, GENETIC;

EID: 3042843645     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800090     Document Type: Article

References (46)

1. Jaffe HL, Lichtenstein L. Solitary unicameral bone cyst with emphasis on the roentgen picture, the pathologic appearances and the pathogenesis. Arch Surg 1942;44: 1004-1025.
2. Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer 1988; 61:2291-2304.
3. Sciot R, Dorfman H, Brys P, et al. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol 2000; 13:1206-1210.
4. Biesecker JL, Marcove RC, Huvos AG, et al. Aneurysmal bone cysts. A clinicopathologic study of 66 cases. Cancer 1970;26:615-625.
5. Dorfman HD, Czeniak B. Giant cell lesions. In: Bone Tumors, CV Mosby, Inc.: St. Louis, 1998.
6. Baruffi MR, Neto JB, Barbieri CH, et al. Aneurysmal bone cyst with chromosomal changes involving 7q and 16p. Cancer Genet Cytogenet 2001;129:177-180.
7. Dal Cin P, Kozakewich HP, Goumnerova L, et al. Variant translocations involving 16q22 and 17p13 in solid variant and extraosseous forms of aneurysmal bone cyst. Genes Chromosomes Cancer 2000;28: 233-234.
8. Herens C, Thirty A, Dresse MF, et al. Translocation (16;17)(q22;p13) is a recurrent anomaly of aneurysmal bone cysts. Cancer Genet Cytogenet 2001;127:83-84.
9. Nielsen GP, Fletcher CDM, Smith MA, et al. Soft tissue aneurysmal bone cyst: a clinicopathologic study of five cases. Am J Surg Pathol 2002;26:64-69.
10. Panoutsakopoulos G, Pandis N, Kyriazoglou I, et al. Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer 1999;26:265-266.
11. Pfeifer FM, Bridge JA, Neff JR, et al. Cytogenetic findings in aneurysmal bone cysts. Genes Chromosomes Cancer 1991;3:416-419.
12. Winnepenninckx V, Debiec-Rychter M, Jorissen M, et al. Aneurysmal bone cyst of the nose with 17p13 involvement. Virchows Arch 2001;439:636-639.
13. Wyatt-Ashmead J, Bao L, Eilert RE, et al. Primary aneurysmal bone cysts: 16q22 and/or 17p13 chromosome abnormalities. Pediatr Dev Pathol 2001;4: 418-419.
14. Nelson M, Perry D, Ginsburg G, et al. Translocation (1;4)(p31;q34) in nonossifying fibroma. Cancer Genet Cytogenet 2003;142:142-144.
15. Safar A, Nelson M, Neff JR, et al. Recurrent anomalies of 6q25 in chondromyxoid fibroma. Hum Pathol 2000;31:306-311.
16. Helman F, (ed). ISCN: An International System for Human Cytogenetic Nomenclature. CT, S. Karger Publishers, Inc.: Farmington, 1995.
17. National Center for Biotechnology Information. http:// www.ncbi.nlm.nih.gov. 2003.
18. The Wellcome Trust Sanger Institute Project Ensembl. http://www.ensembl. org. 2003.
19. Rosenberg AE, Nielsen GP, Fletcher JA. Aneurysmal bone cyst. In: Fletcher CDM, Unni KK, Mertens F (eds). WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, France, 2002, pp 338-339.
20. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol 2001;158: 2089-2096.
21. Dal Cin P, Wanschura S, Christiaens MR, et al. Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY. Genes Chromosomes Cancer 1997;20:90-92.
22. Kazmierczak B, Dal Cin P, Wanschura S, et al. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 1998;23:279-285.
23. Kazmierczak B, Meyer-Bolte K, Tran KH, et al. A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer 1999;26:125-133.
24. Ligon AH, Morton CC. Genetics of uterine leiomyomata. Genes Chromosomes Cancer 2000;28:235-245.
25. Mandahl N, Hoglund M, Mertens F, et al. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 1994;9: 207-215.
26. Miura I, Ohshima A, Takahashi N, et al. A new non-random chromosomal translocation t(3;6)(q27;p21.3) associated with BCL6 rearrangement in two patients with non-Hodgkin's lymphoma. Int J Hematol 1996;64: 249-256.
27. Ohno H, Kerckaert JP, Bastard C, et al. Heterogeneity in B-cell neoplasms associated with rearrangement of the LAZ3 gene on chromosome band 3q27. Jpn J Cancer Res 1994;85:592-600.
28. Pejovic T, Heim S, Mandahl N, et al. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 1992;4:58-68.
29. Tallini G, Dal Cin P, Rhoden KJ, et al. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol 1997;151:37-43.
30. Tallini G, Vanni R, Manifioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 2000;80: 359-369.
31. Thompson FH, Emerson J, Alberts D, et al. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 1994;73: 33-45.
32. Xiao S, Lux ML, Reeves R, et al. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol 1997;150:901-910.
33. Friedmann M, Holth LT, Zoghbi HY, et al. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res 1993;21:4259-4267.
34. Wood LJ, Mukherjee M, Dolde CE, et al. HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol 2000;20:5490-5502.
35. Borg A, Tandon AK, Sigurdsson H, et al. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 1990;50:4332-4337.
36. Gullick WJ, Love SB, Wright C, et al. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 1991;63:434-438.
37. Gusterson BA, Gelber RD, Goldhirsch A, et al. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992;10:1049-1056.
38. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182.
39. Tandon AK, Clark GM, Chamness GC, et al. HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 1989;7:1120-1128.
40. Grimwade D, Lo Coco F. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia 2002; 16:1959-1973.
41. Mistry AR, Pedersen EW, Solomon E, et al. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev 2003;17:71-97.
42. Rowley JD, Golomb HM, Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977;1:549-550.
43. Cancer Genome Anatomy Project. http://cgap.nci.nih. gov. 2003.
44. Weitzmann Institute of Science. http://bioinformatics. weizmann.ac.il. 2003.
45. Lanfrancone L, Pengue G, Pandolfi PP, et al. Structural and functional organization of the HF.10 human zinc finger gene (ZNF35) located on chromosome 3p21-p22. Genomics 1992;12:720-728.
46. Pengue G, Cannada-Bartoli P, Lania L. The ZNF35 human zinc finger gene encodes a sequence-specific DNA-binding protein. FEBS Lett 1993;321:233-236.